The NIH HCQ+AZ trial is useless. On the 2nd day, placebo patients will understand they receive placebo, and will get HCQ+AZ (possibly + Zn) from somewhere else.
If they do blood or urine tests, they will discover that. Mostly placebo patients with light symptoms will continue taking placebo. Thus, even if the NIH researchers remove patients with HCQ/AZ traces in blood or urine, the comparison will remain biased against HCQ+AZ.
via Science Defies Politics
May 18, 2020 at 06:30AM
Iowa Climate Science Education 